Your browser doesn't support javascript.
loading
Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT).
Karolyi, M; Pawelka, E; Omid, S; Koenig, F; Kauer, V; Rumpf, B; Hoepler, W; Kuran, A; Laferl, H; Seitz, T; Traugott, M; Rathkolb, V; Mueller, M; Abrahamowicz, A; Schoergenhofer, C; Hecking, M; Assinger, A; Wenisch, C; Zeitlinger, M; Jilma, B; Zoufaly, A.
Affiliation
  • Karolyi M; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Pawelka E; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Omid S; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Koenig F; Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Kauer V; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Rumpf B; Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
  • Hoepler W; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Kuran A; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Laferl H; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Seitz T; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Traugott M; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Rathkolb V; Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
  • Mueller M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Abrahamowicz A; Faculty of Medicine, Sigmund Freud University, Vienna, Austria.
  • Schoergenhofer C; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Hecking M; Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University of Vienna, Vienna, Austria.
  • Assinger A; Department of Vascular Biology and Thrombosis Research, Center of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Wenisch C; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
  • Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Jilma B; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
  • Zoufaly A; Department for Infectious Diseases and Tropical Medicine, Klinik Favoriten, Vienna, Austria.
Front Pharmacol ; 13: 870493, 2022.
Article in En | MEDLINE | ID: mdl-35935856
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Austria Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Systematic_reviews Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: Austria Country of publication: Suiza